Shahzad Malik
Voorzitter bij Curve Therapeutics Ltd.
Profiel
Shahzad Malik is currently the Chairman of Curve Therapeutics Ltd.
and a Director at Reachora Ltd.
He previously worked as a Non-Executive Director at AviadoBio Ltd.
Actieve functies van Shahzad Malik
Bedrijven | Functie | Begin |
---|---|---|
Curve Therapeutics Ltd.
Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom. | Voorzitter | - |
Reachora Ltd.
Reachora Ltd. Data Processing ServicesTechnology Services Reachora Ltd., through its platform wondr medical, aims to accelerate medical learning and discovery by creating the world's most connected medical network. The company is based in London, UK. The platform is built around healthcare professionals who are driven by curiosity to discover more, from breakthrough research to advances in best practice, and from meeting collaborators to learning from mentors and peers. Wondr medical helps doctors and medical professionals across the world collaborate, connect, and discover medical information. The British company was founded in 2016 by Justin Edgar Rees Davies, who has been the CEO since 2016. | Directeur/Bestuurslid | 05-04-2022 |
Eerdere bekende functies van Shahzad Malik
Bedrijven | Functie | Einde |
---|---|---|
AviadoBio Ltd.
AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Curve Therapeutics Ltd.
Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom. | Commercial Services |
AviadoBio Ltd.
AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Health Technology |
Reachora Ltd.
Reachora Ltd. Data Processing ServicesTechnology Services Reachora Ltd., through its platform wondr medical, aims to accelerate medical learning and discovery by creating the world's most connected medical network. The company is based in London, UK. The platform is built around healthcare professionals who are driven by curiosity to discover more, from breakthrough research to advances in best practice, and from meeting collaborators to learning from mentors and peers. Wondr medical helps doctors and medical professionals across the world collaborate, connect, and discover medical information. The British company was founded in 2016 by Justin Edgar Rees Davies, who has been the CEO since 2016. | Technology Services |